LEESBURG, Va.–(BUSINESS WIRE)–K2M, Inc., a spinal
device company developing innovative solutions for the treatment of complex
spinal pathologies and minimally invasive procedures, today announced the
global launch of the EVEREST™ Degenerative Spinal System at the 2011 North
American Spine Society Annual Meeting (NASS) in Chicago.
“The evolutionary set screw based EVEREST Degenerative
Spinal System provides surgeons with innovative flexibility to address patient
needs.”
The EVEREST Degenerative Spinal System is a top-loading
pedicle screw system featuring the ability to accommodate titanium and cobalt
chrome rods of two different diameters, 5.5 and 6.0 mm, and a screw thread
pitch designed to maximize both osteoporotic and dense bone fixation.
Additionally, this next generation set screw based system features a mixed
material housing intended to minimize head splay, compared to a screw head made
entirely of titanium, as well as improve the biomechanical performance of the
construct. The modified square thread of the locking set screw improves the
fixation characteristics and reduces the potential for cross-threading.
“A combined team of surgeons and engineers worked closely
together to design the EVEREST Degenerative Spinal System, which utilizes both
titanium and cobalt chrome rods and enhances thread pitch for use in both
osteoporotic and dense bone fixation,” stated Dr. John Carbone, Orthopedic
Surgeon at Harborview Reconstructive Spine & Orthopedic Specialists. “In my
opinion, the strength, range of motion, and stiffness of EVEREST provide
surgeons the intraoperative flexibility to address a variety of surgical
pathologies.”
Dr. Carbone will be presenting on the clinical application
of the EVEREST Degenerative Spinal System in a Hands-On Demonstration at NASS,
today at 3:30 pm Central (K2M Booth #1616).
“The expansion of our degenerative product portfolio has
been an important piece of our growth strategy,” stated Eric Major, K2Ms
President and CEO. “The evolutionary set screw based EVEREST Degenerative
Spinal System provides surgeons with innovative flexibility to address patient
needs.”
K2M announced 510(k) clearance from the U.S. Food and Drug
Administration to market EVEREST Degenerative in April 2011. EVEREST
Degenerative can treat Degenerative Disc Disease (DDD), as well as more complex
pathologies.
About K2M
K2M, Inc. is an innovative spinal device company committed to the research,
development, and commercialization of simplified solutions for the treatment of
complex spinal pathologies and minimally invasive procedures. The company is
recognized as a worldwide leader in providing unique technologies for the
treatment of deformity, degenerative, trauma, and tumor spinal patients. K2Ms
complete portfolio of next generation products includes: spinal stabilization
systems, minimally invasive systems, and other advancing technologies such as
motion preservation, annular repair, and nucleus replacement. Additional
information is available online at www.K2M.com.
